论文部分内容阅读
报告４０例胸腺肿瘤合并重症肌无力（ＭＧ）的手术治疗效果。本组包括完全切除肿瘤和胸腺２６例，次全切除肿瘤１０例，组织活检４例。结果手术死亡１例（２．５％），术后１年内死亡８例（２０．５％）。３１例术后随访３～１２年，５年生存率为６１．３％，１０年生存率２７．７％；其中非浸润型胸腺瘤分别为７６．９％和３０．０％，浸润型胸腺瘤则为５０．０％和２５．０％。ＭＧ术后缓解改善率为８０．６％，术后肌无力危象发生率为４０．０％，抢救成功率为９３．８％，结论显示手术治疗胸腺肿瘤合并ＭＧ，如严格掌握手术指征，可获得较好的疗效和预后。
Reported 40 cases of thymic tumors with myasthenia gravis (MG) surgical treatment. This group included 26 cases of complete removal of tumors and thymus, 10 cases of subtotal tumor removal, and 4 cases of tissue biopsy. Results One patient died of surgery (2.5%), and 8 patients (20.5%) died within 1 year after operation. In 31 patients who were followed up for 3 to 12 years, the 5-year survival rate was 61.3%, and the 10-year survival rate was 27.7%. Among them, non-infiltrating thymoma was 76.9% and 30.0%, respectively, and infiltrating thymus. The tumors were 50.0% and 25.0%. The rate of remission improvement after MG was 80.6%, the incidence of postoperative myasthenic crisis was 40.0%, and the rescue success rate was 93.8%. Conclusions indicate that surgical treatment of thymic tumor with MG, such as strict control of surgical indications For better efficacy and prognosis.